Kiniksa Pharmaceuticals, Ltd. revenue breakdown overview

Kiniksa Pharmaceuticals, Ltd. revenue for the last year amounted to 270.26 M USD, the most of which — 270.26 M USD — came from its highest performing source at the moment, Therapeutic Medicines, the year earlier bringing 220.18 M USD. The greatest contribution to the revenue figure was made by Bermuda — last year it brought Kiniksa Pharmaceuticals, Ltd. 270.26 M USD, and the year before that — 220.18 M USD.